Aroda VR, Bain SC, Cariou B et al (2017) Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
However, safety depends on: At a clinical level, dermatologists evaluate: before recommending an IV drip for skin
A new look at the origin, function, and stem-cell status of muscle satellite cells
If you've lost 15% of your body weight on Wegovy and are within 5 pounds of your goal, switching medications introduces new side effects and a titration period that may not be worth it
As long as you are maintaining a caloric deficit and following your personalized treatment plan, a serving of fruit is a healthy way to satisfy a sweet craving
Good stuff